Real-time enrollment status for this bacterial infection clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 10:59 AM UTC
| NCT Number | NCT06462235 |
| Recruiting Status | Recruiting |
| Condition | Bacterial Infection |
| Phase | PHASE2 |
| Target Enrollment | 48 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | June 11, 2026 (Jun 11, 2026) |
As of July 21, 2026: Clinical trial NCT06462235 is currently recruiting participants. This phase2 study for bacterial infection is actively seeking new participants at 11 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06462235 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06462235 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.